Title: Discovery and development of selective human and bacterial agonists of Caseinolytic Protease P (ClpP), as potential anticancer and antibacterial drugs.


The presentation described the on-going research by the CLIP-CAN consortium to design and develop new potent and selective agonists for the human Caseinolytic Protease P protein, as potential anticancer agents.

Leave a Reply